A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microrna target genes

Molecules and Cells

Volumn 34, Issue 4, 2012, Pages 393-398

  Eo, Hae Seok ^a   Heo, Jee Yeon ^a   Choi, Yongjin ^a   Hwang, Youngdon ^a   Choi, Hyung Seok ^a  

^a Future IT RandD Laboratory   (South Korea)

Author keywords

Breast cancer; Classification; Copy number variation; Differentially expressed gene; MicroRNA; Pathway

Indexed keywords

MESSENGER RNA; MICRORNA;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; COPY NUMBER VARIATION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE;

BREAST NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84870312288     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0177-0     Document Type: Article

References (43)

1. Barrett, T., Troup, D.B., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., Marshall, K.A., Phillippy, K.H., Sherman, P.M., et al. (2011). NCBI GEO: Archive for functional genomics data sets-10 years on. Nucleic Acids Res. 39, D1005-D1010.
2. Baselga, J. (2011). Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer. Oncologist 16, 12-19.
3. Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J.C., Huang, J.H., Alexander, A., et al. (2007). Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc. Natl. Acad. Sci. USA 104, 20007-20012.
4. Blenkiron, C., Goldstein, L.D., Thorne, N.P., Spiteri, I., Chin, S.F., Dunning, M.J., Barbosa-Morais, N.L., Teschendorff, A.E., Green, A.R., Ellis, I.O., et al. (2007). MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8, R214.
5. Brown, A.M. (2001). Wnt signaling in breast cancer: Have we come full circle? Breast Cancer Res. 3, 351-355.
6. Cerami, E.G., Gross, B.E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., Schultz, N., Bader, G.D., and Sander, C. (2011). Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39, D685-D690.
7. Chen, D.T., Nasir, A., Culhane, A., Venkataramu, C., Fulp, W., Rubio, R., Wang, T., Agrawal, D., McCarthy, S.M., Gruidl, M., et al., (2010). Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res. Treat. 119, 335-346.
8. Cho, S., Jun, Y., Lee, S., Choi, H.S., Jung, S., Jang, Y., Park, Kim, S., Lee, S., and Kim, W. (2011). miRGator v2.0 : An integrated system for functional investigation of microRNAs. Nucleic Acids Res. 39, D158-162.
9. Chuang, H.Y., Lee, E., Liu, Y.T., Lee, D., and Ideker, T. (2007). Network-based classification of breast cancer metastasis. Mol. Syst. Biol. 3, 140.
10. Dedeurwaerder, S., Desmedt, C., Calonne, E., Singhal, S.K., Haibe-Kains, B., Defrance, M., Michiels, S., Volkmar, M., Deplus, R., Luciani, J., et al. (2011). DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol. Med. 3, 726-741.
11. Desmedt, C., Haibe-Kains, B., Wirapati, P., Buyse, M., Larsimont, D., Bontempi, G., Delorenzi, M., Piccart, M., and Sotiriou, C. (2008). Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin. Cancer Res. 14, 5158-5165.
12. Donahue, T.R., Tran, L.M., Hill, R., Li, Y., Kovochich, A., Calvopina, J.H., Patel, S.G., Wu, N., Hindoyan, A., Farrell, J.J., et al. (2012). Integrative survival-based molecular profiling of human pancreatic cancer. Clin. Cancer Res. 18, 1352-1363.
13. Figueiredo, J.C., Knight, J.A., Cho, S., Savas, S., Onay, U.V., Briollais, L., Goodwin, P.J., McLaughlin, J.R., Andrulis, I.L., and Ozcelik, H. (2007). Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis. BMC Cancer 7, 99.
14. Gu, L., Waliany, S., and Kane, S.E. (2009). Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance. PLoS One 4, e6220.
15. Hawthorn, L., Luce, J., Stein, L., and Rothschild, J. (2010). Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC Cancer 10, 460.
16. Henderson, I.C., and Patek, A.J. (1998). The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res. Treat. 52, 261-288.
17. Huang, W., Sherman, B.T., Stephens, R., Baseler, M.W., Lane, H.C., and Lempicki, R.A. (2008). DAVID gene ID conversion tool. Bioinformation 2, 428-430.
18. Kao, K.J., Chang, K.M., Hsu, H.C., and Huang, A.T. (2011). Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: Implications for treatment optimization. BMC Cancer 11, 143.
19. Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., Richardson, A.L., Polyak, K., Tubo, R., and Wein-berg, R.A. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563.
20. Kaufmann, L.A.R., and Rousseeu, P.J. (1990). Finding Groups in Data: An Introduction to Cluster Analysis (New York: Wiley Inc.
21. Kim, J.H., Kang, S., Kim, T.W., Yin, L., Liu, R., and Kim, S.J. (2012). Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways. Mol. Cells 33, 127-133.
22. Krijgsman, O., Roepman, P., Zwart, W., Carroll, J.S., Tian, S., de Snoo, F.A., Bender, R.A., Bernards, R., and Glas, A.M. (2012). A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. Breast Cancer Res. Treat. 133, 37-47.
23. Lee, E., Chuang, H.Y., Kim, J.W., Ideker, T., and Lee, D. (2008). Inferring pathway activity toward precise disease classification. PLoS Comput. Biol. 4, e1000217.
24. Loi, S., Haibe-Kains, B., Majjaj, S., Lallemand, F., Durbecq, V., Larsimont, D., Gonzalez-Angulo, A.M., Pusztai, L., Symmans, W.F., Bardelli, A., et al. (2010). PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. Proc. Natl. Acad. Sci. USA 107, 10208-10213.
25. Lu, X., Lu, X., Wang, Z.C., Iglehart, J.D., Zhang, X., and Richardson, A.L. (2008). Predicting features of breast cancer with gene expression patterns. Breast Cancer Res. Treat. 108, 191-201.
26. Nordgard, S.H., Johansen, F.E., Alnaes, G.I., Bucher, E., Syvänen, A.C., Naume, B., Børresen-Dale, A.L., and Kristensen, V.N. (2008). Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 47, 680-696.
27. Oliveira, A.L., Rodrigues, F.F., Santos, R.E., Aoki, T., Rocha, M.N., Longui, C.A., and Melo, M.B. (2010). GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Genet. Mol. Res. 9, 1045-1053.
28. Parker, J.S., Mullins, M., Cheang, M.C., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009). Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160-1167.
29. Pedraza, V., Gomez-Capilla, J.A., Escaramis, G., Gomez, C., Torné, P., Rivera, J.M., Gil, A., Araque, P., Olea, N., Estivill, X., et al. (2010). Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. Cancer 116, 486-496.
30. Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
31. Pusztai, L., Cristofanilli, M., and Paik, S. (2007). New generation of molecular prognostic and predictive tests for breast cancer. Semin. Oncol. 34, S10-S16.
32. Qu, S., Cai, Q., Gao, Y.T., Lu, W., Cai, H., Su, Y., Wang, S.E., Shu, X.O., and Zheng, W. (2008). ERBB2 genetic polymorphism and breast cancer risk in Chinese women: A population-based casecontrol study. Breast Cancer Res. Treat. 110, 169-176.
33. Richardson, A.L., Wang, Z.C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J.D., Livingston, D.M., and Ganesan, S. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132.
34. Ross, J.S. (2009). Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Adv. Anat. Pathol. 16, 204-215.
35. Ross, J.S., Hatzis, C., Symmans, W.F., Pusztai, L., and Hortobágyi, G.N. (2008). Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist 13, 477-493.
36. Rouzier, R., Perou, C.M., Symmans, W.F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K.R., Stec, J., Ayers, M., Wagner, P., et al. (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res. 11, 5678-5685.
37. Sircoulomb, F., Bekhouche, I., Finetti, P., Adélaïde, J., Ben Hamida, A., Bonansea, J., Raynaud, S., Innocenti, C., Charafe-Jauffret, E., Tarpin, C., et al., (2010). Genome profiling of ERBB2-amplified breast cancers. BMC Cancer 10, 539.
38. Smid, M., Wang, Y., Zhang, Y., Sieuwerts, A.M., Yu, J., Klijn, J.G., Foekens, J.A., and Martens, J.W. (2008). Subtypes of breast cancer show preferential site of relapse. Cancer Res. 68, 3108-3114.
39. Sontrop, H.M., Verhaegh, W.F., Reinders, M.J., and Moerland, P.D. (2011). An evaluation protocol for subtype-specific breast cancer event prediction. PLoS One 6, e21681.
40. Sørlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874.
41. Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Kaushik, P., Cerami, E., Reva, B., et al. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22.
42. Turashvili, G., Bouchal, J., Baumforth, K., Wei, W., Dziechciarkova, M., Ehrmann, J., Klein, J., Fridman, E., Skarda, J., Srovnal, J., et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 27, 55.
43. van't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.